Specialty Pharmaceutical Partnering Terms and Agreements 2020-2026

$3,995.00

Specialty Pharmaceutical Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals. 

Publication date
March 2026
Number of pages
550+
Product type
Research report
Report edition
6
SKU
CP1017

Benchmark Partnering Strategies Across the Specialty Pharmaceutical Sector

Free report sample

The Global Specialty Pharmaceutical Partnering Terms and Agreements report provides a comprehensive analysis of partnering agreements across the global specialty pharmaceutical industry. Designed for business development, licensing, and corporate strategy professionals, the report delivers detailed insight into how companies structure partnerships to develop, commercialize, and distribute specialty pharmaceutical products.

The report analyzes specialty pharmaceutical agreements announced since 2020, offering a detailed view of how companies collaborate across research, development, licensing, and commercialization partnerships.

Through a combination of deal data, financial benchmarking, and access to real contract documents, the report allows users to understand how and why companies enter specialty pharmaceutical partnerships and what financial and contractual terms define these agreements.

Each deal entry links to a detailed online deal record and, where available, the underlying contract document filed with regulators, providing direct access to the contractual terms negotiated between partners.


Key Benefits

Save Significant Research Time
Access a consolidated resource covering hundreds of specialty pharmaceutical agreements rather than searching multiple press releases, filings, and industry databases.

Benchmark Specialty Pharma Deal Structures
Understand how companies structure specialty pharmaceutical partnerships, including collaboration, licensing, development, and commercialization arrangements.

Analyze Financial Deal Terms
Review available data on headline deal values, upfront payments, milestone payments, and royalty structures to benchmark financial terms across comparable agreements.

Access Real Contract Documents
Where available, explore actual partnership agreements filed with regulators, enabling detailed analysis of the contractual provisions behind real-world deals.

Identify the Most Active Specialty Pharmaceutical Dealmakers
Discover which companies are leading partnering activity and analyze their collaboration strategies.

Track Industry Trends
Analyze specialty pharmaceutical partnering activity since 2020 across technologies, therapeutic areas, and development stages.


What’s Included in the Report

  • Analysis of specialty pharmaceutical dealmaking trends since 2020

  • Overview of partnering structures and financial models used in specialty pharma collaborations

  • Review of leading specialty pharmaceutical deals by disclosed value

  • Profiles of the most active specialty pharmaceutical dealmakers

  • Detailed analysis of deals organized by company, stage of development, therapy area, and technology type

  • A comprehensive directory of specialty pharmaceutical partnerships

  • Links to online deal records and contract documents where available

Deals are indexed in multiple ways—including company A–Z, deal value, development stage, technology type, and therapy target—making it easier to identify comparable transactions.


Due Diligence Insights from Real Agreements

By reviewing actual partnering contracts, the report enables users to evaluate key provisions such as:

  • Rights granted or licensed under the agreement

  • Financial payment structures and royalty terms

  • Intellectual property ownership and licensing scope

  • Development and commercialization responsibilities

  • Exclusivity provisions and territorial rights

  • Contract duration and termination clauses

Access to real agreements provides insight into the detailed terms negotiated between companies—information rarely disclosed in press releases or summary deal databases.


Why This Report Matters

Specialty pharmaceuticals represent one of the fastest-growing segments of the life sciences industry, with companies increasingly relying on strategic partnerships to develop and commercialize innovative therapies.

By combining comprehensive deal data, financial benchmarking, and access to real contract agreements, this report provides the intelligence needed to evaluate partnership opportunities, benchmark deal terms, and negotiate more effective specialty pharmaceutical collaborations.

Key Benefits

Save Significant Research Time
Access a consolidated resource covering hundreds of specialty pharmaceutical agreements rather than searching multiple press releases, filings, and industry databases.

Benchmark Specialty Pharma Deal Structures
Understand how companies structure specialty pharmaceutical partnerships, including collaboration, licensing, development, and commercialization arrangements.

Analyze Financial Deal Terms
Review available data on headline deal values, upfront payments, milestone payments, and royalty structures to benchmark financial terms across comparable agreements.

Access Real Contract Documents
Where available, explore actual partnership agreements filed with regulators, enabling detailed analysis of the contractual provisions behind real-world deals.

Identify the Most Active Specialty Pharmaceutical Dealmakers
Discover which companies are leading partnering activity and analyze their collaboration strategies.

Track Industry Trends
Analyze specialty pharmaceutical partnering activity since 2020 across technologies, therapeutic areas, and development stages.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in specialty pharmaceutical dealmaking

 

2.1. Introduction

2.2. Specialty pharmaceutical partnering over the years

2.3. Most active specialty pharmaceutical dealmakers

2.4. Specialty pharmaceutical partnering by deal type

2.5. Specialty pharmaceutical partnering by therapy area

2.6. Specialty pharmaceutical partnering by technology type

2.7. Deal terms for specialty pharmaceutical partnering

2.7.1 Specialty pharmaceutical partnering headline values

2.7.2 Specialty pharmaceutical deal upfront payments

2.7.3 Specialty pharmaceutical deal milestone payments

2.7.4 Specialty pharmaceutical royalty rates

 

Chapter 3 – Leading specialty pharmaceutical deals

 

3.1. Introduction

3.2. Top specialty pharmaceutical deals by value

 

Chapter 4 – Most active specialty pharmaceutical dealmakers

 

4.1. Introduction

4.2. Most active specialty pharmaceutical dealmakers

4.3. Most active specialty pharmaceutical partnering company profiles

 

Chapter 5 – Specialty pharmaceutical contracts dealmaking directory

 

5.1. Introduction

5.2. Specialty pharmaceutical contracts dealmaking directory

 

Chapter 6 – Specialty pharmaceutical dealmaking by technology type

 

Appendices

 

Appendix 1 – Specialty pharmaceutical deals by company A-Z

Appendix 2 – Specialty pharmaceutical deals by stage of development

Appendix 3 – Specialty pharmaceutical deals by deal type

Appendix 4 – Specialty pharmaceutical deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Specialty pharmaceutical partnering since 2020

Figure 2: Active specialty pharmaceutical dealmaking activity since 2020

Figure 3: Specialty pharmaceutical partnering by deal type since 2020

Figure 4: Specialty pharmaceutical partnering by disease type since 2020

Figure 5: Specialty pharmaceutical partnering by technology type since 2020

Figure 6: Specialty pharmaceutical deals with a headline value

Figure 7: Specialty pharmaceutical deals with an upfront value

Figure 8: Specialty pharmaceutical deals with a milestone value

Figure 9: Specialty pharmaceutical deals with a royalty rate value

Figure 10: Top specialty pharmaceutical deals by value since 2020

Figure 11: Most active specialty pharmaceutical dealmakers since 2020

 

Pricing options

 

  • $3,995: single-user
  • $5,995: multi-user
  • $7,995: corporate/enterprise license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3B Pharmaceuticals, 4C Labs, 22nd Century, 48Hour Discovery, 111, 180 Life Sciences, Aadi Bioscience, Abba Medix, Abbvie, Abera Bioscience, Abingworth Life Sciences, Ablaze Pharmaceuticals, ABX, Accord Healthcare, ACEA Therapeutics, AcedrA BioPharmaceuticals, Acelrx Pharmaceuticals, Aceto Corporation, Acino Pharma, Acorda Therapeutics, Actinium Pharmaceuticals, AcuCort, Acumen Analytics, Adalvo, Adare Pharma Solutions, Adastra Labs, Adelia Therapeutics, Adhex Pharma, Adial Pharmaceuticals, Adjupharm, Advanced Accelerator Applications, Advancell, Advanz Pharma, Advent Therapeutics, Advicenne, Aelis Pharma, Aequus Pharmaceuticals, Aerami Therapeutics, AEssenseGrows, Aesthetic Management Partners, AEterna Zentaris, Afaxys Pharmaceuticals, AFT Pharmaceuticals, Agenus Bio, Aggrega Pharma, Agilent Technologies, Agile Therapeutics, AgraFlora Organics International, Agritek, Agro-Greens Natural Products, Aguettant, AIDS Foundation Houston, AIkido Pharma, AimMax Therapeutics, Ainos, Aion Therapeutic, Aither Ingredient, AiVita Biomedical, AJNA BioSciences, Akanda, Akerna, Akome Biotech, Aktis Oncology, Alar Pharmaceuticals, ALASTIN Skincare, Albany Molecular Research, Alcami, Alcresta Therapeutics Inc, Aleafia Health, Alessa Therapeutics, Alex Therapeutics, Alimera Sciences, Alkemist Labs, Alkermes, Allarity Therapeutics, Allele Genetics, Alliancepharma Technologies, AllianceRx Walgreens Prime, Allied Corp, Ally Biotech, Alpha-9 Oncology, Alphamind Brands, Alpine Hemp Group, Altan Pharma, Altasciences, Alteogen, Alternative Solutions, Altimmune, Altopa, Altruix, Altum Pharmaceuticals, Alumis, Alvotech, AmacaThera, AMF Medical, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Amring Pharmaceuticals, Amryt Pharma, Amyris, Amzell, ANANDA Scientific, Andros Pharmaceuticals, AnGes MG, ANI Pharmaceuticals, AnnJi Pharmaceutical, Antares Pharma, Antiverse, APCNA Holdings, Apical Biotek, Apipharm Veletrgovina, Apollo Green, Apollon Formularies, Apoteka, Apotex, Applied Biology, Applied Botanics, Applied DNA Sciences, Applied Pharmaceutical Innovation, APR Applied Pharma Research, Aquestive Therapeutics, Arbor Biotechnologies, Arbormentis, Arbor Pharmaceuticals, Arcade Therapeutics, Arcadia Biosciences, ARC Dialysis, Arctic Vision, Ardena, Arecor Therapeutics, Areva Med, Argentia Gold, Armas Pharmaceuticals, ARTBIO, Arvelle Therapeutics, Asahi Kasei, Asarina Pharma, Ascendis Pharma, Ascent Clinical Research, Asia Green Biotechnology, Aspargo Laboratories, Assertio Therapeutics, AssistRx, Astellas Pharma, Astria Therapeutics, ATAI Life Sciences, Atalo, Athebio, Athena Bioscience, ATMA Journey Centers, AtomVie Global Radiopharma, Aureuspharma, Aurora Cannabis, Australian Nuclear Science and Technology Organisation, Auxly Cannabis Group, Avadel Pharmaceuticals, Avanzanite Bioscience, Avenue Therapeutics, Averix Bio, Avextra, Avicanna, Avida Global, Aviko Radiopharmaceuticals, Awakened Biosciences, Awakn Life Sciences, Aytu BioPharma, Azanta, Azurity Pharmaceuticals, BAMF Health, Basilea Pharmaceutica, Batavia Biosciences, Bausch Health Companies, Bavarian Nordic, Baxter International, Bayer, BayMedica, Beckley Psytech, BellRock Brands, Belmar Pharma, Beta Bionics, Better Choice Company, BetterLife Pharma, Better Therapeutics, BevCanna, Bexson Biomedical, Bilthoven Biologicals, Bio-Gate, Bio-Sourcing, Bio-Thera Solutions, BioAgronomics, Bioarc, BioDelivery Sciences, Biohaven Pharmaceuticals, Bio Lab Naturals, BioLab Sciences, Biolife Science, Biolinear Technologies, BiolineRX, Biological E, Biomunex Pharmaceuticals, Biopas Laboratories, Biopharmaceutical Research Company, BioPharma Services, BioRAE, BioScript Solutions, BioSenic, BioSyent, BioSyent Pharma, Biotron Laboratories, BioVectra, BioXcel, BIRAD Research and Development Company, Bison & Rose, BLLRDR, Bloom Medicinals, Blueberries Medical, Blue Note Therapeutics, Blue Wolf Capital Partners, BodyLogicMD, Boehringer Ingelheim, Bophelo Bioscience & Wellness, Bora Pharmaceuticals, Boston Scientific, Botanical, Boudicca Dx, Braeburn Pharmaceuticals, Brains Bioceutical, Braxia Scientific, Breath of Life International, Breckenbridge Pharmaceutical, Brigham and Women's Hospital, Bristol-Myers Squibb, British Columbia Liquor Distribution Branch, BTG Specialty Pharmaceuticals, Burleigh Heads Cannabis, Bushu Pharmaceuticals, BWXT Medical, California Institute for Biomedical Research, Caligor, Calliditas Therapeutics, Calyptus Pharmaceuticals, Camino Pharma, Canada House Wellness Group, Canadian Institutes of Health Research, CanaQuest Medical, Canavation Product Group, Cancer Prevention and Research Institute of Texas, CanMart, Cannabics Pharmaceuticals, Cannabis Global, Cannabis House, Cannabis Manufacturer’s Guild, Cannabis Medical Solutions, Cannabis Suisse, Cannabotech, CannaBR Exports, CannaCure, Cannafeels, CannaGlobal Wellness, CannaHive, Cannamedical Pharma, Cannaponics, Cannara Biotech, CannaSoul Analytics, Cannassure Therapeutics, Cannaworx, Cannex Scientific, Cannidex Brands, Cannim Australia, Cannomed Medical Cannabis Industries, Canntab Therapeutics, CannTx Life Sciences, Cannvalate, Canonic, Canopy Growth, CanProbe, Cantek, Cantourage, Cap Alter Pharma, Capna Intellectual, Cardiovascular Solutions of Central Mississippi, Carestream Health, Cassiopea, Catalent, CBD Export Global, cbdMD, CBD Supply MD, CBD Vida, CB Therapeutics, CC Pharma, Ceautamed Worldwide, Celanese, CellBion, Cellen Life Sciences, Celltrion, Cellular Goods, Cena Life, Centre for Addiction and Mental Health, Centre for Human Drug Research, Centre for Probe Development and Commercialization, Charlotte's Web, Checkpoint Therapeutics, Chengdu Gaotong Isotope, Chiesi Farmaceutici, Chiesi Global Rare Diseases, Chimerix, China Grand Pharmaceutical, China Medical System, Chr Hansen, Christina Lake Cannabis, ChromaDex, CH Trading Group, Cimeio Therapeutics, Cipher Pharmaceuticals, Citius Oncology, Citrine Medicine, CIVCO Radiotherapy, Clarion Medical Technologies, Clarity Pharmaceuticals, Clarus Therapeutics, Clearmind Medicine, Clearwater Canngrow, Clerkenwell Health, Clinigen, Clinilabs, Clinlogix, Clionix, Closed Loop Medicine, Clovis Oncology, CNAO Foundation, CNBX Pharmaceuticals, CNX Therapeutics, Coave Therapeutics, COEUS Healthcare, Coherus Biosciences, Coldhaus Distribution, Collegium Pharmaceuticals, Columbia Care, Columbia University, Compassionate Cultivation, Compound Genetics, Concentric Analgesics, CONTINUUS Pharmaceuticals, Convergent Therapeutics, Core One Labs, CoreRx Pharma, CorMedix, Correvio Pharma, Cosette Pharmaceuticals, Cosma Cannabis, Cosmofix, Covis Pharmaceutical, Cream of the Crop Therapeutics, Cresco Labs, Cristalia, Croda, Crohn's and Colitis Foundation of America, Crossject, CSL, CStone Pharmaceuticals, Curadh MTR, Curaleaf, Curavit Clinical Research, CURE Pharmaceutical, Curia, Curie Therapeutics, Curio Wellness, Curium, Cutia Therapeutics, CVC Capital Partners, CV Sciences, Cybin, Cycle Pharmaceuticals, Cyclica, Cyclo Therapeutics, Cyprium Therapeutics, Daewoong Pharmaceutical, DanCann Pharma, Danish Innovation Fund, DannCan Pharma, Dare Bioscience, DarioHealth, Day One Biopharmaceuticals, Debiopharm, Decibel Cannabis Company, Defence Research and Development Canada, Defence Therapeutics, Delic, Delta, Delta 9 Cannabis, Demetrix, Denali Capital Acquisition Corp, Densitas, Department of Defense, Department of Health and Human Services, Dermata Therapeutics, Desert Medical Campus, Devonian Health Group, Dexcel Pharma, DiagnaMed, Diamond Therapeutics, Diaprost, Diurnal, Diverchim, Divergence Neuro Technologies, DKSH, Docklight Brands, Dompe Farmaceutici, Dona Blanca, Dosecann, DoubleRainbow Biosciences, Dr. Denese SkinScience, Dr. Reddy's Laboratories, Dreamy, DRI Capital, Dr Kerklaan Therapeutics, DSM, Duke-NUS Graduate Medical School Singapore, Duke University, Durbin Group, Dutch Emotional Brain, Dynavax Technologies, Eagle Pharmaceuticals (US), EA Pharma, Eckert & Ziegler, Ecogen, Eczacıbasi-Monrol, Edenbridge Pharmaceuticals, Edge Pharma, Edison Nation, EffRx Pharmaceuticals, Ei.Ventures, Eiger BioPharmaceuticals, EirGen Pharma, Eledon Pharmaceuticals, Elekta, Eleusis, Elevar Therapeutics, Eli Lilly, Embark Health, EMC Pharma, Emerald Family Farms, Empyrean Medical Systems, Encore Life, Endo, Endocanna Health, Endo International, Endo Pharmaceuticals, Enogenesis, Enosis Therapeutics, Ensho Therapeutics, Ensysce Biosciences, Entheon Biomedical, Enthusiasmus, Entoura, Entourage Health, Entourage Phytolab, Enveric Biosciences, Enzolytics, EPI Health, Equillium, Er-Kim, ESJ Enterprises, Esperion Therapeutics, Essential Pharma, Estar Medical, Esteve, Ethypharm, Eton Pharmaceuticals, EUSA Pharma, Eve & Co, Evergreen Theragnostics, Eversana, Evogene, Evoke Pharma, Evolution Research Group, ExCEEd Orphan, Exela Pharma Sciences, EXMceuticals, Exotic Genetix, Experion Biotechnologies, Eybna Technologies, EyeCare Services Partners, EyeCRO, Eyeganics, Eyegate Pharmaceuticals, Eyenovia, EyePoint Pharmaceuticals, Fabre Kramer Pharmaceuticals, Farco Pharma, Farmalider, FarmaMondo Group, FCM Global, Feel Better, Feel Ventures, Fennec Pharmaceuticals, Filament Health, FivepHusion, Florida State University, Fluence, Fluence Bioengineering, Fluum, Foamix Pharmaceuticals, Focus-X Therapeutics, FogPharma, Forcefield Therapeutics, ForDoz Pharma, Foreseen Biotechnology, Foresee Pharmaceuticals, Formosa Pharmaceuticals, Formycon, Fosun Pharmaceutical, Freeline Therapeutics, Freya Pharma Solutions, Frost Pharma, FSD Pharma, Full-Life Technologies, Full Alliance Group, Full Spectrum Biosciences, Fuse Oncology, Fusion Pharmaceuticals, FutureChem, Fuzionaire, Gad Medical Equipment, Gage Cannabis, Galderma, Galera Therapeutics, Gallery Brands, GAMA, Gamida Cell, GB Sciences, GE Healthcare, Gelesis, Genetica, GeniusRx, Genomind, Geocann, George Clinical, George Mason University, Georgetown University, Gesval, GetHealthy, Glaukos, Glenmark Pharmaceuticals S.A., Global Cannabinoids, Global Hemp Group, Glooko, Glytherix, go NXT LVL, Gossamer Bio, Government of Canada, Grace Fine Chemicals, Graystone Company, Great North Distributors, Greene Street Pharmaceuticals, Greenstein Germany, Green Stripe Naturals, Greenteaspoon, Grove Collaborative, GroVida, Grupo Curativa, GSW Creative Corporation Canada, GT Medical Technologies, GT Research, Guerbet, GVB Biopharma, GW Pharmaceuticals, HAI Health, Halo Labs, Halozyme Therapeutics, Halucenex Life Sciences, HaluGen Life Sciences, Handa Pharmaceuticals, Handok Pharmaceuticals, Hanfpost, Hansa Biopharma, Harm Reduction Therapeutics, Harvest One, Haukeland University Hospital, Havn Life Sciences, Headwater Cannabis, Health Box, Health Decisions, Health House International, HealthTech Connex, Hebrew University of Jerusalem, Helmholtz Zentrum Munchen, Helsinn Healthcare, Hemispherian, HempFusion Wellness, Hempsana, HemPup, Hepion Pharmaceuticals, Herbolea Biotech, Heritage Cannabis, Hexo, High Beauty, High Times, Hikma Pharmaceuticals, HLS Therapeutics, HMNRTH, Hofseth BioCare, Holigen, Hollister Biosciences, Honor Epic Enterprises, Hormosan Pharma GmbH, Hoth Therapeutics, Hybrid Pharm, Hyloris Pharmaceuticals, Hypha Wellness, Hyphens, Iambic Therapeutics, IBA, iBrands, iCAD, ICL, Ilera Holistic Healthcare, ImaginAb, IM Cannabis, ImCheck Therapeutics, Immedica, ImmuNext, Immunocore, IMP Clinical Supply Services, Impilo, Impopharma, ImprimisRx, Incannex Healthcare, Indegene Lifesystems, Indivior, InfuSystem Holdings, iNGENu, Inhibrx, InMed Pharmaceuticals, InnoPharmax, Innovate UK, Innoviva, Innoviva Specialty Therapeutics, Insud Pharma, Intas Pharmaceuticals, Intec Pharma, IntelGenx, InterCure, International Hyperhidrosis Society, IntuitiveX, Ionetix, Ionic Brands, ipCapital Group, IPMC, Ipsen, iQone Healthcare, Ironshore Therapeutics, Irwin Naturals, Isologic Innovative Radiopharmaceuticals, IsoRay, Isosceles Pharmaceuticals, IsoTherapeutics, Isotopia Molecular Imaging, ITM Isotopen Technologien, iX Biopharma, Jackson Laboratory, Jaguar Health, Jamieson, JAMP Pharma Group, JanOne, Janssen Pharmaceutica NV, Jazz Pharmaceuticals, Jennewein Biotechnologie, Jianming Pharmaceutical, J Molner, Johns Hopkins University, Johnson & Johnson, Jolt Health, Journey Medical, Jubilant Radiopharma, Jungle Med, Juniper Therapeutics, Juno Pharmaceuticals Canada, Jupiter Wellness, JustCBD, Kadenwood, Kaivalya Kollectiv, Kaken Pharmaceutical, Kali-Extracts, KalVista Pharmaceuticals, Kanabo Research, Kashiv BioSciences, Kayagene, Kazmira, KD Pharma, Kelai Pharmaceuticals, Kemin Industries, Kensing, Kensington Pharma, Kenya Medical Research Institute, Key2Brain, KGK Science, Khiron Life Sciences, Khon Kaen University, Kindeva Drug Delivery, Kiora Pharmaceuticals, Klaria, Klinge Biopharma, Knight Therapeutics, Kohlberg Kravis Roberts (KKR), Komtur Pharmaceuticals, KOR Medical, Koyo Foods, Kubota Vision, Kura Oncology, KVK-Tech, Kymanox, Kyowa Hakko Kirin, L-3 Communications, Laboratoires DELBERT, Laboratoire Serb, Laboratoires Thea, Lannett, Lantheus Holding, Launchit Ventures, Launch Therapeutics, Lavie Bio, Lawley Pharmaceuticals, Leo Cancer Care, LEO Pharma, Leriva, Leucid Bio, Levitee Labs, Life Molecular Imaging, Life Time, Linden Capital Partners, Lindis Biotech, Linnea Cannabinoids, Lisata Therapeutics, Livzon Pharmaceutical, Lobe Sciences, Lobo Genetics, Lotus Pharmaceuticals, Louis Widmer, LOVE Pharma, LTS Lohmann Therapie-Systeme, Lucid Psycheceuticals, Lucy Scientific Discovery, Lumiera Health Innovation, Lunatus, Lune Rise Farms, Lupin, Lupin Limited, Lupin Pharmaceuticals, LYF Food Technologies, Lygos, M8 Pharmaceuticals, Maastricht University, MaaT Pharma, mAbXience, Macrocyclics, Macrogenics, Magdalena Biosciences, MagicMed Industries, Magnolia Extracts, MAIA Pharmaceuticals, Makana Therapeutics, Mallinckrodt Pharmaceuticals, Maple Leaf Green World, Maplex Naturals, Marengo Therapeutics, Marinus Pharmaceuticals, Marius Pharmaceuticals, Massachusetts General Hospital, Mass General Brigham, Matai Medical Research Institute, Materia, Mayne Pharma, McGill University, McKesson, McMaster University, MD Anderson Cancer Center, Mechelen, Medara, MedBright AI, Medcolcanna Organics, Medical Cannabis by Shoppers, Medican Enterprises, Medicanmentos de Cannabis, Medice Arzneimittel Pütter, MedinCell, MediPharm Labs, Medipost, Medisca, MediSynergics, Medocann Pharma, MedPharm, Medsenic, Med Tech Farms, Megalabs, Megapharm, Melinta Therapeutics, Memorial Sloan Kettering Cancer Center, Mendo Medical, MenoLabs, Merck and Co, Merck KGaA, Merdury Biopharmaceutical, MetaMe Health, MGC Pharma, Michigan State University, MicroDoz Therapy, Millennium, MIND Foundation, Mind Medicine, Mindset Pharma, MindShift Compounds, miraDry, Mira Pharmaceuticals, Mirum Pharmaceuticals, MISTR, Mithra Pharmaceuticals, Mitsubishi Tanabe Pharma, Mitsui, MM Technology, Moberg Pharma, Molecular Partners, Molecular Targeting Technologies, Molecule.ai, Molteni Farmaceutici, Monash University, Mondias Natural Products, Monopar Therapeutics, Montreal Cannabis Medical, Mota Ventures, Mountain Valley MD, MPB Group, MPX International, MS Pharma, MTP Material, MycoMeditations, Myconic Capital, Mycotopia Therapies, Mycovia Pharmaceuticals, Mycrodose Therapeutics, Mydecine Group, MYND Life Sciences, MyoKardia, MYOS, myTomorrows, Naari Pharma, Nabriva Therapeutics, Nacuity Pharmaceuticals, Nalu Bio, Nanjing Hanxin Pharmaceutical Technology, Nanoform, Nanomerics, Nanopharmaceutics, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Standards and Technology, National Institute on Drug Abuse (NIDA), National Institutes of Health, Navamedic, Navigo Proteins, Neauvia North America, Neeka Health, Negev Labs, Neobiomics, NeoLumina Bioscience, NeonMind Biosciences, Neos Therapeutics, Neox, Neptune Wellness Solutions, Nestle Health Science, NetCann, Neumentum, Neuraxpharm, Neurelis, NeuroBiogen, Neurogastrx, NeuroPharm, NeuroTheryX, Neutron Therapeutics, New Age Nanotech, NewBridge Pharmaceuticals, NewCanna Hub, NewFaDem, NewLeaf Brands, New Leaf Canada, Newly Institute, New Path Laboratories, Newron Pharmaceuticals, Nextage Therapeutics, Next Frontier Pharmaceuticals, Nextleaf Solutions, NFL Biosciences, Niagen Bioscience, Nicoya, Nimbus Health, NineteenGale Therapeutics, Niowave, Nirvana Life Sciences, Nivagen Pharmaceuticals, NLS Pharmaceutics, Noble Growth, Node Labs, Noden Pharma, Nora Pharma, Nordic Nanovector, Norgine, Northern Green Canada, North Star Holdings, NorthStar Medical Radioisotopes, NovaBay Pharmaceuticals, Nova Mentis Life Science, Novamind, Novan, Nova Pharmaceuticals, Novartis, Novo Integrated Sciences, Novo Nordisk, Nrgene, NRG Oncology, NRx Pharmaceuticals, Nuance Pharma, Nucleus RadioPharma, Nucliber, Nuclidium, Numab, Numinus Wellness, Nurosene, Nusano, NutraGyst, NutraLife Biosciences, Nutrawise Health & Beauty, Nutriband, Nutrition21, Nuvation Bio, Nxera Pharma, NXTGEN, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, ODI Pharma, OETTINGER Brauerei, OG DNA Genetics, OG Laboratories, Oklahoma Medical Research Foundation, Old Pal, Omega Laboratories, Omni Medical Products, Onco360, Oncopeptides, OneLife Botanicals, One Small Planet, OnKure, Open Book Extracts, Opiant Pharmaceuticals, Opiostop, OPKO Health, Opticann, Optimi Health, OptiNose, Optum Frontier Therapies, Orano Med, Orbimed Advisors, Orbis Biosciences, Orbis Medicines, Orbit Discovery, Orbus Therapeutics, Orchard Therapeutics, Orexo, Organic Remedies, Organigram, Origami Therapeutics, Orion, OrphanDC, Orpharm, ORPHELIA Pharma, Orsini Healthcare Specialty Pharmacy, Oryx Isotopes, Ovation Science, OVID Health Systems, Ovid Therapeutics, OWP Pharmaceuticals, Pacific Sun Fungi, Pacira Biosciences, Padagis, Paladin Labs, Panaxia, Pantera, PANTHERx Specialty Pharmacy, PanTheryx, PA Options for Wellness, ParaPRO, Paratek Pharmaceuticals, Parent Company, Parkinson's Disease Foundation, Park Therapeutics, Particle Dynamics, Pascal Biosciences, Pasithea Therapeutics, Pathway Health, Pathway Rx, Pax Labs, PDL BioPharma, Peak Pharm Labs, PEAR Therapeutics, PECET, Pendopharm, Perennial, Perrigo, Persist AI, Perspective Therapeutics, Petalfast, Petros Pharmaceuticals, Pfizer, Pharma15, PharmaCielo, PharmaDrug, PharmAla Biotech, PharmaLogic, Pharmanovia, PharmaTher, Pharma Two B, Pharmicated, Pharming Group, PhaseV, Phebra, Phil, Philadelphia College of Osteopathic Medicine Foundation, Philip Morris, Philochem, Phinest Cannabis, Phlo, Phlow, PH Precision Med, Phylloceuticals, Phyto Extractions Brands, Pilz Bioscience, Pioneer Knop Laboratorios, Planet 13, Planet Green BioTechnology, Plantations Ceres, Pleasure Peaks, Pleco Therapeutics, Plena Global, Plus Therapeutics, POINT Biopharma, Polaris Group, PolyPid, Polyrizon, Portocanna, Pramantha Group, Precirix, Precision Molecular, Premier Inc, Premium 5, Pressure BioSciences, Prestige BioPharma, Prime Therapeutics, Primevera Therapeutics, Primm Pharma, Primo Nutraceuticals, Procaps, Project Cannabis, Promises Innovative Recovery Center, ProPharma Group, Prosoma Digital Therapeutics, Provepharm, Psirenity, PsyBioMed – Australia, Psycheceutical Bioscience, Psychedelic Society Belgium, Psyence Biomedical, Psyence Therapeutics, Psygen Labs, Puma Biotechnology, Puration, PurCann Pharmaceuticals, Purdue Pharma, Pure Extracts Technologies, PureForm Global, Pure Origin, Purisys, Purna Pharmaceuticals, Pyros Pharmaceuticals, Q BioMed, QOL Medical, Quadri Pharmaceuticals, Quoin Pharmaceuticals, Quotient, Radient Technologies, Radiomedix, Radiopharm Theranostics, Radiopharm Ventures, Radius Health, Radius Pharmaceuticals, Rafael Holdings, Rafarma Pharmaceuticals, Rapid Dose Therapeutics, Ratio Therapeutics, RayzeBio, RCK, Realm of Caring, Rebel Edibles, Recipharm, Recover Together, RedHawk, RedHill Biopharma, Red Light Holland, Red White & Bloom Brands, Redwood Scientific Technologies, Regencell Bioscience, Regeneron Pharmaceuticals, Regor Therapeutics, ReLeaf Europe, Relief Therapeutics, Relmada Therapeutics, Renaissance Pharma, Reneo Pharmaceuticals, REPO4EU, Repurpose.AI, Reset Pharmaceuticals, Respira Technologies, Respira Therapeutics, Revance Therapeutics, Reverie Labs, Reverie Psychedelics, ReVision Optics, Revive Therapeutics, Rhoshan Pharmaceuticals, Rigel Pharmaceuticals, Rigour International, Rise Wellness, RK Pharma, RLS, Roche, Rocket VR Health, Rockwell Medical, Ro Invest, Roivant Sciences, Rosemont Pharmaceuticals, Royalty Pharma, RS BioTherapeutics, Rubicon Research, Rutgers University, RX Pharmatech, Ryerson University, S.Biomedics, SABI Mind, Safer Medical of Montana, Safe Sea, Sagely Enterprises, Sage Therapeutics, Sairiyo Therapeutics, Samsung Bioepis, Sandhill One, Sanford Burnham Institute, Saniona, Sanofi, Sanpellegrino Cosmetics, Sansero Life Sciences, Sante Laboratories, Santen Pharmaceutical, Santhera Pharmaceuticals, Saol Therapeutics, Sciensus Rare, Scientific Research Council, Scilex Holding, Scipher Medicine, SciSparc, SCK CEN, Scripps Research Institute, Searchlight Pharma, Seelos Therapeutics, Segra International, Seibersdorf Laboratories, Semnur Pharmaceuticals, Sen-Jam Pharmaceutical, Sensus Healthcare, Sentynl Therapeutics, Seqirus, Sera Labs, SERB Pharmaceuticals, Seres Therapeutics, Sermonix Pharmaceutical, Sernova, Shanti Therapeutics, Shenzhen Qianzhi, Shilpa Biologicals, Shine Medical Technologies, SHINE Technologies, Shionogi, Shoppers Drug Mart, Shorla Oncology, Shorla Pharma, Short Wave Pharma, ShroomBloom, Shuttle Pharmaceuticals, Sidero Bioscience, SIFI (Societa Industria Farmaceutica Italiana), Silexion Therapeutics, SiliCycle, Silk Road Medical, Silo Pharma, Silo Wellness, Simcere Zaiming, Siren Biotechnology, Siva Therapeutics, Sixty Degrees Pharmaceuticals, SK Biopharmaceuticals, SKNY Pharmaceuticals, Skye Bioscience, SkyePharma, Skyhawk Therapeutics, Slayback Pharma, SmartCella, Smart for Life, Smart Supplement, Smartway Pharmaceuticals, SNDL, Sofie Biosciences, Soin Therapeutics, Sol-Gel, Solumedics, SOMAI Pharmaceuticals, Sona Nanotech, Sonoma Pharmaceuticals, Sorse Technology, Sosei Heptares, Southern Glazer's Wine & Spirits, SpectronRx, Spectrum Health, Spenta, Spore Life Sciences, Sproutly, SRS Life Sciences, SRx Health, STADA Arzneimittel, Stalicla, Stanley Capital, Stark Investments, Starpharma, SteinCares, Stenocare, Steriscience, Stevanato, Strides Pharma Science, Suanfarma, Sugarbud Craft Growers, Summit Biosciences, Sundaily, Sunderstorm, Sun Pharmaceutical, Superior Biologics, Supernus Pharmaceuticals, Supreme Cannabis, Supriya Lifescience, Sutro Biopharma, Suzuken, Swinburne University, Swing Therapeutics, Swixx Biopharma, Swysh, SymbioPharm, Symeres, Syneos Health, Synergy Aesthetics, Synthon, Synthonics, TAAT Lifestyle & Wellness, Tactical Relief, TAE Life Sciences, TaGeza Biopharma, Taiho, Takeda Pharmaceutical, Tandem Diabetes Care, Tanner Pharma, Tanner Pharmaceuticals, TargEDys, Targeted Pharmaceutical, Tasman Pharma, Taste-T, Tauriga Sciences, Tautomer Bioscience, Teikoku Seiyaku, Telix Pharmaceuticals, Tenacia Biotechnology, Tenax Therapeutics, Tergus Pharma, Terrace Global, Terragenx, TerraPower, TerrAscend, TerSera Therapeutics, TerThera, Tesaro, Tetra Bio-Pharma, Tetraphase Pharmaceuticals, Tetris Pharma, Teva Pharmaceutical Industries, Teva Pharmaceuticals USA, TG Therapeutics, Thar Process, The Access to Advanced Health Insitute (AAHI), The Green Organic Dutchman Holdings, The Nutraceutical Medicine Company, Theragnostics, Therakind, Therakos, Theramex, TherapeuticsMD, Therapeutic Solutions International, Therapix Bio, TheraPsil, Theratechnologies, Therismos, Thor Medical, Thorne HealthTech, Tikun Olam, Tikun Olam-Cannbit, Tilray, Tioga Research, Titan Pharmaceuticals, TLC BioSciences, Together Pharma, TONIX Pharmaceuticals, Toronto Centre for Psychedelic Science, Transcend Biodynamics, Transcoject, Translational Medicine Accelerator, Treehill Partners, Tris Pharma, Tritium 3H, TRIUMF, TRON Group, TRP, True North Cannabis, Truss Beverage, TryptageniX, Tryp Therapeutics, Tsime Pharmaceuticals and Medicinal Supplies, Tulane University, Tulex Pharmaceuticals, TWi Biotechnology, TwinPharma, Ultragenyx Pharmaceuticals, UMass Memorial Medical Center, United States Pharmacopeia, Univar, Universal Ibogaine, Universidade Estadual de Campinas, University College Cork, University Health Network, University of Antwerp, University of Arizona, University of British Columbia, University of Calgary, University of California, San Diego (UCSD) School of Medicine, University of California Los Angeles, University of California San Francisco, University of Cincinnati, University of Colorado, University of Health Sciences Antigua, University of Leuven, University of Maryland Baltimore, University of Miami Miller School of Medicine, University of Michigan, University of Nebraska, University of Queensland, University of Rochester Medical Center, University of Saskatchewan, University of South Australia, University of Southern California, University of Texas, University of Toronto, Unravel Biosciences, UpHealth, UPPI, US Army, US Government, Valbiotis, Valens Company, Valneva, Vanguard Scientific Systems, Vault Health, Vaxil BioTherapeutics, VB Brands California, Vector Institute, Vector Pharma FZCO, Vectura, Vektor Pharma, Ventis Pharma, Verde Leaf, VerdePharmHealth, Verinetics, Verity Pharmaceuticals, Verse Cannabis, Vertical Pharmaceuticals, Veterans For Healing, ViaDerma, Viatris, Vici Health Sciences, Vida Concepts, Vifor Pharma, Viridian Sciences, Virpax Pharmaceuticals, Vision Essence, Vitae Naturals, Vital Proteins, VIVO Cannabis, Vivtex, Vocan Biotechnologies, VYNE Therapeutics, Waters Corporation, WB Canna & Wellness, WeedMD, WEP Clinical, Wesana Health, WholeScripts, Willow Biosciences, Windsong Radiology, Winhealth Pharma Group, World Orphan Drug Alliance, Worldwide Clinical Trials, Wuhan General Group, X-chem, X4 Pharmaceuticals, Xediton Pharmaceuticals, XERIS Pharmaceuticals, XLR8 Brazil, XPhyto Therapeutics, Xylo Technologies, Y-mAbs Therapeutics, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, Yummi Karma, YVY Life Sciences, Zelira Therapeutics, Zenabis, Zerion Pharma, Zhejiang Yonghe Pharmaceutical Technology, Zion Medical, Zydus Cadila, Zydus Lifesciences, Zylo Therapeutics, ZYUS Life Sciences, ZyVersa Therapeutics

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!